01 3Rosuzet
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 68
2020 Revenue in Millions : 130
Growth (%) : -48
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 71
2021 Revenue in Millions : 68
Growth (%) : 4
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 70
2022 Revenue in Millions : 71
Growth (%) : -1
LOOKING FOR A SUPPLIER?